BioCentury
ARTICLE | Company News

Management tracks

June 23, 2015 1:38 AM UTC

Rare disease play Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) named Jayson Dallas chief commercial officer, effective Aug. 3. Dallas was general manager in the U.K. at Roche (SIX:ROG; OTCQX:RHHBY).

Hepatic company Intercept Phamaceuticals Inc. (NASDAQ:ICPT) named Juan Carlos Lopez-Talavera SVP of medical affairs. Lopez-Talavera was head of hepatology R&D and VP of medical affairs at AbbVie Inc. (NYSE:ABBV). ...